RXRX vs VRDN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

RXRX

44.1
AI Score
VS
RXRX Wins

VRDN

43.8
AI Score

Investment Advisor Scores

RXRX

44score
Recommendation
HOLD

VRDN

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric RXRX VRDN Winner
Revenue 14.14M 4.16M RXRX
Net Income -248.51M -3.52M VRDN
Net Margin -1757.1% -84.7% VRDN
Operating Income -263.47M -6.99M VRDN
ROE -27.2% -54.7% RXRX
ROA -20.5% -39.0% RXRX
Total Assets 1.21B 9.04M RXRX
Cash 545.68M 8.38M RXRX
Current Ratio 5.03 3.07 RXRX
Free Cash Flow -187.35M -8.85M VRDN

Relative Price Performance (Last 90 Days)

RXRX 1M: -2.7% · 3M: +1.6% VRDN 1M: -7.2% · 3M: +31.6%

Current Technical Phase

RXRX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 46

RSI (14): 45.6 · Price: $3.20

VRDN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 39

RSI (14): 38.7 · Price: $21.24

Fundamentals Snapshot

Metric RXRX VRDN
Market Cap
Forward P/E -3.6 -7.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 2.8%
Gross Margin -7.2% -3.6%
Operating Margin -17.6% -444.6%
EPS -0.98 -3.33
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.